Innoviva, Inc. (INVA)

Nasdaq: INVA · Pharmaceutical Preparations · Burlingame, CA · filing with the SEC since 2000

Grade6.2

◀ Past 6.4● Present 6.5▶ Future 5.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 25, 2026	Feb 26, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 25, 2021	Feb 19, 2020	Feb 19, 2019	Feb 23, 2018	Feb 28, 2017
Revenue	411,328	358,711	310,463	331,339	391,866	336,794	261,016	261,004	217,217	133,569
For lenders
Interest and dividend income	21,086	19,141	15,818	6,369	1,839	1,524	5,540	·	·	·
Interest and investment income	·	·	·	·	·	1,524	5,540	1,660	1,311	582
Gross profit	307,667	296,211	246,039	·	·	·	·	·	·	·
Research and development	30,604	13,654	33,922	41,432	576	1,788	0	0	1,355	1,393
Selling, general and administrative	113,318	115,690	98,232	63,538	16,187	13,883	·	·	·	·
General and administrative	·	·	·	·	16,187	13,883	14,656	20,053	32,258	23,188
Total operating expenses	143,922	129,344	132,154	·	16,763	15,671	14,656	22,753	33,613	24,581
Total costs and expenses	·	321,323	116,365	44,390	-53,410	-17,451	·	·	·	·
Operating income	163,745	166,867	113,885	·	375,103	321,123	246,360	238,251	183,604	108,988
Interest expense	16,698	22,209	19,157	15,789	19,070	18,331	18,660	23,954	43,601	52,416
Share of profit of equity-method investments	141,433	-64,253	77,392	-161,749	84,392	49,511	·	·	·	·
Other income (expense), net	-2,864	-2,997	-4,969	-3,373	-3,626	-348	-345	-5,702	-7,038^r	2,477^r
Income before income taxes	326,862	37,388	194,098	286,949	445,276	354,245	232,895	210,255	134,276	59,631^r
Income tax expense	55,697	13,996	14,376	66,687	76,439	60,431	41,902	-196,073	4	95
Income from discontinued operations	·	·	·	·	·	·	·	·	·	0
Net income including non-controlling interests	271,165	23,392	179,722	220,262	368,837	293,814	190,993	406,328	134,272	59,536
Net income to non-controlling interests	·	0	0	6,341	102,983	69,412	33,705	11,272	129	0
Net income to common shareholders	271,165	23,392	179,722	213,921	265,854	224,402	157,288	395,056	134,143	59,536
Earnings per share, basic	4.02	0.37	2.75	3.07	3.24	2.21	1.55	3.92	1.25	0.54
Earnings per share, diluted	3.30	0.36	2.20	2.37	2.87	2.02	1.43	3.53	1.17	0.53
Weighted average shares, basic	67,395	62,726	65,435	69,644	82,062	101,320	101,150	100,849	106,945	110,280
Weighted average shares, diluted	84,760	74,187	86,876	95,248	94,310	113,554	113,409	113,408	119,866	123,233

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Interest and dividend income what its loans and securities earnedus-gaap:InterestAndDividendIncomeOperating

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton INVA · research, not advice